NOUS-209 Off-the-shelf Immunotherapy Has the Potential to Hit Primary and Metachronous Colorectal and Urothelial Cancers in Lynch Syndrome
Lorenzo De Marco(Nouscom (Italy)), Toni T. Seppälä(University of Helsinki)
Cited by 2
Related Papers
Combination of microsatellite instability and BRAF mutation status for subtyping colorectal cancer
|British Journal of Cancer|2015|153
Comprehensive characterization of micropapillary colorectal adenocarcinoma
|The Journal of Pathology|2025|10
High immune cell infiltration predicts improved survival in cholangiocarcinoma
|Frontiers in Oncology|2024|8
Urothelium marker UPK2 identifies aggressive colorectal cancers with distinct molecular and histological features
|British Journal of Cancer|2025|0
Tumor Invasive Border Index ( <scp>TIBI</scp> ) in colorectal cancer: linking infiltrative morphology to molecular insights
|The Journal of Pathology|2026|0